Literature DB >> 30931055

Utility of a Finger-Mounted Tissue Oximeter with Near-Infrared Spectroscopy to Evaluate Limb Ischemia in Patients with Peripheral Arterial Disease.

Tatsuro Yata1,2, Masaki Sano1,2, Takafumi Kayama1,2, Ena Naruse1,2, Naoto Yamamoto1,2,3, Kazunori Inuzuka1,2, Takaaki Saito1,2, Kazuto Katahashi1,2, Yuta Yamanaka1,2,3, Toshiyuki Uchida4, Masatsugu Niwayama5, Naohiro Kanayama4, Hiroya Takeuchi2, Naoki Unno1,2,3.   

Abstract

Objective: To investigate whether a finger-mounted tissue oximeter is useful in evaluating limb blood flow in patients with peripheral arterial disease (PAD). Materials and
Methods: Seventy-two patients with PAD were included, and the ankle-brachial index (ABI), transcutaneous oxygen pressure (TcPO2), and skin perfusion pressure (SPP) were measured. The regional tissue oxygenation saturation (rSO2) was measured using a finger-mounted tissue oximeter at the ankle, dorsal foot, and each dorsal and plantar toe. Correlations between rSO2 and ABI and between TcPO2 and SPP were analyzed. The patients were divided into three groups: Fontaine IIa (F-IIa), IIb (F-IIb), and III and IV (F-III/IV) groups. The difference in rSO2 between each group was analyzed.
Results: Significant correlations were observed between rSO2 and TcPO2 and between rSO2 and SPP. TcPO2 and SPP in the F-III/IV group were significantly lower than those in the F-IIa group. rSO2 in the F-IIb and F-III/IV groups was significantly lower than that in the F-IIa group.
Conclusion: The measurement of rSO2 using finger-mounted tissue oximetry is quick, simple, and painless. It can be used on any skin area and is useful to evaluate limb circulation in patients with PAD.

Entities:  

Keywords:  limb blood flow; near-infrared spectroscopy; peripheral arterial disease; regional hemoglobin oxygen saturation

Year:  2019        PMID: 30931055      PMCID: PMC6434358          DOI: 10.3400/avd.oa.18-00117

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  5 in total

1.  Perioperative patient-controlled regional analgesia versus patient-controlled intravenous analgesia for patients with critical limb ischaemia: a study protocol for a randomised controlled trial.

Authors:  Si Chen; Zhonghuang Xu; Hongju Liu; Yuelun Zhang; Jiao Zhang; Yuexin Chen; Yuehong Zheng; Yuguang Huang
Journal:  BMJ Open       Date:  2020-10-08       Impact factor: 2.692

2.  A Pilot Study Investigating the Use of Regional Oxygen Saturation as a Predictor of Ischemic Wound Healing Outcome after Endovascular Treatment in Patients with Chronic Limb-Threatening Ischemia.

Authors:  Takafumi Kayama; Masaki Sano; Kazunori Inuzuka; Kazuto Katahashi; Tatsuro Yata; Yuta Yamanaka; Ena Naruse; Naoto Yamamoto; Hiroya Takeuchi; Naoki Unno
Journal:  Ann Vasc Dis       Date:  2021-03-25

3.  Term Newborns with relatively low Tissue Oxygen Saturation Levels soon after Birth are predisposed to Neonatal Respiratory Disorders in Low-risk, Elective Cesarean Sections.

Authors:  Kenta Kawai; Toshiyuki Uchida; Mari Mukai; Masako Matsumoto; Toshiya Itoh; Tomoaki Oda; Yoshimasa Horikoshi; Kazunao Suzuki; Yukiko Kohmura-Kobayashi; Naomi Furuta-Isomura; Chizuko Yaguchi; Masatsugu Niwayama; Hiroaki Itoh; Naohiro Kanayama
Journal:  Int J Med Sci       Date:  2021-03-30       Impact factor: 3.738

4.  The Patency of Tibial/Peroneal Arteries Affects the Increment of Regional Tissue Saturation of Oxygen in Each Angiosome after Superficial Femoral Artery Revascularization.

Authors:  Naoki Unno; Kazunori Inuzuka; Naoto Yamamoto; Masaki Sano; Kazuto Katahashi; Takafumi Kayama; Tatsuro Yata; Yuta Yamanaka; Hajime Tsuyuki; Yusuke Endo; Nozomu Ishikawa; Ena Naruse; Masatsugu Niwayama; Hiroya Takeuchi
Journal:  Ann Vasc Dis       Date:  2022-03-25

5.  Real-time assessment of tissue oxygen saturation during endovascular therapy for chronic limb threatening ischemia using a novel oximeter.

Authors:  Naoki Unno; Kazunori Inuzuka; Masaki Sano; Masatsugu Niwayama; Ena Naruse; Hiroya Takeuchi
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.